Sponsor:
University of Chicago
Code:
NCT05700617
Conditions
Heart Failure
Cardiogenic Shock
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
1:1 Randomization to receive milrinone
Brief summary:
Conditions
Heart Failure
Cardiogenic Shock
Study ID
NCT05700617
Start date
Jul 6, 2023
Status verified date
Aug, 2026
Completion date
Dec, 2027
Anticipated
Primary completion date
Dec, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
5 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
active comparator: 1:1 Randomization to Milrinone
no intervention: 1:1 No Intervention
Interventions
1:1 Randomization to receive milrinone
Primary outcome measure
Central contacts
Daniel Rodgers
drodgers3@uchgicagomedicine.orgLocations
The University of Chicago
Recruiting
Chicago, Illinois, United States, 60637
Contacts
Sponsor
University of Chicago
Last update posted
Aug 6, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Chicago on 2026-08-06.